Publications in collaboration with researchers from Hospital de la Santa Creu i Sant Pau (1)

2022

  1. An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol

    Gates Open Research, Vol. 6